Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates

Respiratory Medicine

Volumn 107, Issue 7, 2013, Pages 943-952

  Donohue, James F ^a   Jain, Neal ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MARICOPA MEDICAL CENTER   (United States)

Author keywords

Airway inflammation; Asthma; Asthma exacerbation rates; Corticosteroid responsiveness; Exhaled nitric oxide

Indexed keywords

CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; FRACTIONAL EXHALED NITRIC OXIDE; IMMUNOGLOBULIN E; NITRIC OXIDE; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ASTHMA; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG TREATMENT FAILURE; EXHALATION; HELPER CELL; HUMAN; LUNG FUNCTION; LUNG TRANSPLANTATION; MEDICATION COMPLIANCE; PEAK EXPIRATORY FLOW; PREDICTIVE VALUE; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; REVIEW; TH2 CELL; TIME TO TREATMENT; TREATMENT RESPONSE;

ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; DRUG ADMINISTRATION SCHEDULE; GLUCOCORTICOIDS; HUMANS; NITRIC OXIDE; POINT-OF-CARE SYSTEMS; PROGNOSIS; RISK ASSESSMENT; TH2 CELLS; TREATMENT OUTCOME;

EID: 84878904002     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.02.018     Document Type: Review

References (71)

1. Akinbami LJ, Moorman JE, Bailey C. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS data brief, no. 94; May 2012.
2. S.B.L. Barnett, and T.A. Nurmagambetov Costs of asthma in the United States: 2002-2007 J Allergy Clin Immunol 127 2011 145 152
3. American Lung Association. Trends in asthma morbidity and mortality. Available from: [accessed September 20, 2012].
4. R.A. Nathan, E.O. Meltzer, and M.S. Blaiss Comparison of the Asthma in America and Asthma Insight and Management surveys: did asthma burden and care improve in the United States between 1998 and 2009? Allergy Asthma Proc 33 2012 65 76
5. S. Pakhale, A. Sumner, D. Coyle, K. Vandemheen, and S. Aaron Correcting misdiagnoses of asthma: a cost effectiveness analysis BMC Pulm Med 11 2011 27
6. D. Caudri, A.H. Wijga, and H.A. Smit Asthma symptoms and medication in the PIAMA birth cohort: evidence for under and overtreatment Pediatr Allergy Immunol 22 2011 652 659
7. N. Pearce, J. Pekkanen, and R. Beasley How much asthma is really attributable to atopy? Thorax 54 1999 268 272 (Pubitemid 29110510)
8. J. Douwes, P. Gibson, J. Pekkanen, and N. Pearce Non-eosinophilic asthma: importance and possible mechanisms Thorax 57 2002 643 648 (Pubitemid 34761769)
9. K.W. McGrath, N. Icitovic, and H.A. Boushey A large subgroup of mild-to-moderate asthma is persistently noneosinophilic Am J Respir Crit Care Med 185 2012 612 619
10. D.M. Durrant, and D.W. Metzger Emerging roles of T helper subsets in the pathogenesis of asthma Immunol Invest 39 2010 526 549
11. K. Alving, and A. Malinovschi Basic aspects of exhaled nitric oxide Eur Respir Mon 49 2010 1 31
12. R.A. Dweik, P.B. Boggs, and S.C. Erzurum An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FeNO) for clinical applications Am J Respir Crit Care Med 184 2011 602 615
13. P. Haldar, C.E. Brightling, and B. Hargadon Mepolizumab and exacerbations of refractory eosinophilic asthma N Engl J Med 360 2009 973 984
14. J. Corren, R.F. Lemanske, and N.A. Hanania Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
15. J. Lotvall, C.A. Akdis, L.B. Bacharier, and L. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome J Allergy Clin Immunol 127 2011 355 360
16. S.T. Holgate, and R. Polosa The mechanisms, diagnosis, and management of severe asthma in adults Lancet 368 2006 780 793 (Pubitemid 44279056)
17. W.C. Moore, D.A. Meyers, and S.E. Wenzel Identification of asthma phenotypes using cluster analysis in the severe asthma research program Am J Respir Crit Care Med 181 2010 315 323
18. D.C. Cowan, J.O. Cowan, R. Palmay, A. Williamson, and D.R. Taylor Effects of steroid therapy on inflammatory cell subtypes in asthma Thorax 65 2010 384 390
19. M.A. Berry, D.E. Shaw, R.H. Green, C.E. Brightling, A.J. Wardlaw, and I.D. Pavord The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma Clin Exp Allergy 35 2005 1175 1179
20. Y. Sivan, T. Gadish, E. Fireman, and R. Soferman The use of exhaled nitric oxide in the diagnosis of asthma in school children J Pediatr 155 2009 211 216
21. D.R. Taylor, M.W. Pijnenburg, A.D. Smith, and C.D. Jongste Exhaled nitric oxide measurements: clinical application and interpretation Thorax 61 2006 817 827 (Pubitemid 44369409)
22. Z. Zietkowski, A. Bodzenta-Lukaszyk, M.M. Tomasiak, R. Skiepko, and M. Szmitkowski Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naïve asthma patients J Investig Allergol Clin Immunol 16 2006 239 246 (Pubitemid 44198445)
23. D. Cordeiro, A. Rudolphus, E. Snoey, and G.-J. Braunstahl Utility of nitric oxide for the diagnosis of asthma in an allergy clinic population Allergy Asthma Proc 32 2011 119 126
24. K.C. See, and D.C. Christiani Normal values and thresholds for the clinical interpretation of exhaled nitric oxide levels in the U.S. General Population: results from NHANES 2007-2010 Chest 143 2013 107 116
25. D.R. Taylor Advances in the clinical applications of exhaled nitric oxide measurements J Breath Res 6 2012 1 8
26. A.D. Smith, J.O. Cowan, and S. Filsell Diagnosing asthma. Comparisons between exhaled nitric oxide measurements and conventional tests Am J Respir Crit Care Med 169 2004 473 478 (Pubitemid 38187119)
27. A.D. Smith, J.O. Cowan, and K.P. Brassett Exhaled nitric oxide. A predictor of steroid response Am J Respir Crit Care Med 172 2005 453 459 (Pubitemid 41117391)
28. J.M. Chatkin, K. Ansarin, and P.E. Silkoff Exhaled nitric oxide as a noninvasive assessment of chronic cough Am J Respir Crit Care Med 159 1999 1810 1813 (Pubitemid 29275047)
29. K. Kowal, A. Bodzenta-Lukaszyk, and S. Zukowski Exhaled nitric oxide in evaluation of young adults with chronic cough J Asthma 46 2009 692 698
30. M.J. Oh, J.Y. Lee, B.J. Lee, and D.C. Choi Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough Chest 134 2008 990 995
31. P.Y. Hahn, T.Y. Morgenthaler, and K.G. Lim Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough Mayo Clin Proc 82 2007 1350 1355 (Pubitemid 350060130)
32. L.A. Perez-de-Llano, F. Carballada, and O. Castro Añon Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma Eur Respir J 35 2010 1221 1227
33. A. Sverrid, C. Porsbjerg, S.F. Thomsen, and V. Backer Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: a random-sample population study J Allergy Clin Immunol 126 2010 952 958
34. F.N. Schleich, R. Asandei, M. Manise, J. Sele, L. Seidel, and R. Louis Is FENO50 useful diagnostic tool in suspected asthma? Int J Clin Pract 66 2012 158 165
35. A. Schneider, L. Tilemann, and T. Schermer Diagnosing asthma in general practice with portable exhaled nitric oxide measurement - results of a prospective diagnostic study Resp Res 10 2009 15
36. National Jewish Health Consensus statement on the use of fractional exhaled nitric oxide in the clinical management of asthma Available from: December 2009 http://www.njhealth.org [accessed June 27, 2012]
37. G. Rolla, G. Guida, and E. Heffler Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma Chest 131 2007 1345 1352
38. G. Guida, G. Rolla, and I. Badiu Determinants of exhaled nitric oxide in chronic rhinosinusitis Chest 137 2010 658 664
39. T. Garriga, M. Labrador-Horrillo, and M. Guillén Spirometric maneuvers and inhaled salbutamol do not affect exhaled nitric oxide measurements among patients with allergic asthma Respiration 83 2012 239 244
40. H.L. Petsky, C.J. Cates, A. Li, J.A. Lynaston, C. Turner, and A.B. Chang Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults (review) Cochrane Database Syst Rev 2 2009 CD006340
41. H.L. Petsky, C.J. Cates, and T.J. Lasserson A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils) Thorax 67 2012 199 208
42. H. Powell, V.E. Murphy, and D.R. Taylor Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomized controlled trial Lancet 378 2011 983 990
43. A.D. Smith, J.O. Cowan, K.P. Brassett, G.P. Herbison, and D.R. Taylor Use of exhaled nitric oxide measurements to guide treatment in chronic asthma N Engl J Med 352 2005 2163 2173
44. D.E. Shaw, M.A. Berry, and M. Thomas The use of exhaled nitric oxide to guide asthma management Am J Respir Crit Care Med 176 2007 231 237
45. J.C. De Jongste, S. Carraro, W.C. Hop, the CHARISM Study Group, and E. Baraldi Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma Am J Respir Crit Care Med 179 2009 93 97
46. M.W. Pijnenburg, E.M. Bakker, W.C. Hop, and J.C. de Jongste Titrating steroids on exhaled nitric oxide in children with asthma Am J Respir Crit Care Med 172 2005 831 836 (Pubitemid 41369065)
47. S.J. Szefler, H. Mitchell, and C.A. Sorkness Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomized controlled trial Lancet 372 2008 1065 1072
48. A. Fuhlbrigge, D. Peden, and A.J. Apter Asthma outcomes: exacerbations J Allergy Clin Immunol 129 2012 S34 S48
49. W.J. Calhoun, B.T. Ameredes, and T.S. King Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial JAMA 308 2012 987 997
50. R.S. Zeiger, M. Schatz, and F. Zhang Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids J Allergy Clin Immunol 128 2011 412 414
51. A.F. Gelb, C.F. Taylor, C.M. Shinar, C. Gutierrez, and N. Zamel Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics Chest 129 2006 1492 1499 (Pubitemid 43894977)
52. S.L. Jones, J. Kittelson, and J.O. Cowan The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control Am J Respir Crit Care Med 164 2001 738 743 (Pubitemid 32881906)
53. A. Zacharasiewicz, N. Wilson, and C. Lex Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children Am J Respir Crit Car Med 171 2005 1077 1082 (Pubitemid 40663717)
54. A. Deykin, S.C. Lazarus, and J.V. Fahy Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids J Allergy Clin Immunol 115 2005 720 727 (Pubitemid 40460845)
55. J.D. Leuppi, C.M. Salome, and C.R. Jenkinds Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids Am J Respir Crit Care Med 163 2001 406 412 (Pubitemid 32158520)
56. J. Beck-Ripp, M. Griese, S. Arenz, C. Köring, B. Pasqualoni, and P. Bufler Changes of exhaled nitric oxide during steroid treatment of childhood asthma Eur Respir J 19 2002 1015 1019 (Pubitemid 34649612)
57. C. Delgado-Corcoran, N. Kissoon, S.P. Murphy, and L.J. Duckworth Exhaled nitric oxide reflects asthma severity and asthma control Pediatr Crit Care Med 5 2004 48 52
58. M.G. Cochrane, M.V. Bala, K.E. Downs, J. Mauskopf, and R.H. Ben-Joseph Inhaled corticosteroids for asthma therapy Chest 117 2000 542 550
59. J.B. Soriano, K.J. Davis, B. Coleman, G. Visick, D. Mannino, and N.B. Pride The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom Chest 124 2003 474 481 (Pubitemid 37000122)
60. K.M. Beeh, O. Kornmann, J. Beier, M. Ksoll, and R. Buhl Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease Respir Med 98 2004 591 597 (Pubitemid 38949921)
61. A.A. Zeki, M. Schivo, A. Chan, T.E. Albertson, and S. Louie The asthma-COPD overlap syndrome: a common clinical problem in the elderly J Allergy 2011 Epub Oct 30
62. P.G. Gibson, V.M. McDonald, and G.B. Marks Asthma in older adults Lancet 376 2010 803 813
63. P.M.A. Calverley, R.A. Stockley, and T.A.R. Seemungal Reported pneumonia in patients with COPD Chest 139 2011 505 512
64. A. Langhammer, S. Forsmo, and U. Syversen Long-term therapy in COPD: any evidence of adverse effect on bone? Int J COPD 4 2009 365 380
65. I.A. Yang, M.S. Clarke, E.H. Sim, and K.M. Fong Inhaled corticosteroids for stable chronic obstructive pulmonary disease Cochrane Database Syst Rev 7 2012 Jul 11 CD002991
66. B. Antus, I. Barta, I. Horvath, and E. Csiszer Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations Respirology 15 2010 472 477
67. K.M. Kunisaki, K.L. Rice, E.N. Janoff, T.S. Rector, and D.E. Niewoehner Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled futicasone propionate in severe chronic obstructive pulmonary disease: a prospective study Ther Adv Respir Dis 2 2008 55 64 (Pubitemid 351472131)
68. Z. Zietkowski, I. Kucharewicz, and A. Bodzenta-Lukaszyk The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease Respir Med 99 2005 816 824 (Pubitemid 40796555)
69. J.F. Dummer, M.J. Epton, and J.O. Cowan Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide Am J Respir Crit Care Med 180 2009 846 852
70. K. Akamatsu, K. Matsunaga, and H. Sugiura Improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease: what is the specific marker? Front Pharmacol 2 2011 36
71. C. Neurohr, P. Huppmann, and S. Leuschner Usefulness of exhaled nitric oxide to guide risk stratification for bronchiolitis obliterans syndrome after lung transplantation Am J Transplant 11 2011 129 137